• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Christine E. Chaisson, MPH

Latest:

Teamwork Enhances Patient Experience: Linking TEAM and Net Promoter Scores

In 1386 providers, better teamwork related to higher patient Net Promoter Score (NPS), and the relationship between provider experience and NPS was mediated by teamwork.


Louis D. Falo Jr, MD, PhD

Latest:

Access to Consultative Dermatologic Care via Physician-to-Physician Asynchronous Outpatient Teledermatology

Direct access of primary care physicians to dermatologists via asynchronous teledermatology improves a health system’s ability to increase patient access to dermatologic care.



Toby Maher, MD, PhD

Latest:

Impact of Treatment Delays on Patient Outcomes

Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.


Jürgen Unützer, MD, MPH, MA

Latest:

Effective Implementation of Collaborative Care for Depression: What Is Needed?

Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.



Alex Sripipatana, PhD, MPH

Latest:

Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 Years

This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.


Lin Xie, MS, MA

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Nicola Lancki, MPH

Latest:

Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications

Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.


Karen Shakiba, BS

Latest:

Increasing Medicare Annual Wellness Visits in Accountable Care Organizations

Through innovations increasing the ease of scheduling and the efficiency of conducting annual wellness visits (AWVs), a large Medicare accountable care organization has been able to increase AWV rates among eligible beneficiaries.


Carrie Nagorka

Latest:

Asthma, Eczema Associated With Higher Risk for Osteoarthritis

The study findings suggest that treatments for allergic reactions could help decrease the risk of having joint problems.




Greg I. Sawchyn, MD

Latest:

A Case Report of the Analytic Development of Bundled Payments for the Commercial Market

This case report of a novel methodology for the analytic development of bundled payments addresses statistical analysis, data visualization, and clinical consultation.


Sabree C. Burbage, PharmD, MPH

Latest:

COPD Treatment Ratio: A Measure for Improving COPD Population Health

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.


Theodore S. Z. Berkowitz, MS

Latest:

Predictors of Discharge From the VA Caregiver Support Program

The year of application predicts discharge from the Department of Veterans Affairs (VA) caregiver program. Unexpected, disallowed criteria also predict discharge, with significant others facing higher discharge risk than spouses.


Jesús Matarranz, PhD

Latest:

Process Reengineering and Patient-Centered Approach Strengthen Efficiency in Specialized Care

Improving efficiency is complex and requires a multimodal approach. Health information systems, patient feedback, and multidisciplinary teams are components that can improve clinical processes.


Yelena Nabutovsky, MS

Latest:

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a cohort of 10,282 adults with type 2 diabetes.


Anne Hume, PharmD

Latest:

Association of Guideline-Concordant Care With Survival, Health Care Utilization, and Costs Among Older Women With Advanced Epithelial Ovarian Cancer

Non–guideline-concordant care for ovarian cancer was associated with higher all-cause and cancer-specific mortality, increased health care utilization, and increased Medicare expenditures, highlighting opportunities for improving cancer care in this vulnerable group.


Tiange Zhan, MS

Latest:

Machine Intelligence for Early Targeted Precision Management and Response to Outbreaks of Respiratory Infections

This paper evaluates novel machine intelligence to predict patients at risk of severe respiratory infections and recommend postacute care providers likely to reduce infection risk.


Justin Oldham, MD, MS

Latest:

Unmet Needs in IPF Landscape

Critical voids in the management of idiopathic pulmonary fibrosis are discussed by Justin Oldham, MD, MS.


David L. DeMets, PhD

Latest:

COVID-19 Control in the United States: The Case for Masking

In the control of COVID-19, the future perfect of the vaccine should not be the enemy of the present good, which is masking.


Charles Stoecker, PhD

Latest:

Non–Face-to-Face Care Management and Service Utilization in Patients With Diabetes

CMS began reimbursement for non–face-to-face chronic care management in 2015, and results from Louisiana show that it increases outpatient visits but decreases inpatient and emergency department encounters.


Matthew D. Eisenberg, PhD

Latest:

The Impact of HDHPs on Service Use and Spending for Substance Use Disorders

Offering a high-deductible health plan (HDHP) led to a 6.6% reduction in the probability of using substance use disorder services and a shift in spending from the plan to the enrollee.


Jingwei Ren, MS

Latest:

At-Home Hemoglobin A1c Testing During COVID-19 Improved Glycemic Control

Providing at-home hemoglobin A1c test kits increases testing rates and facilitates hemoglobin A1c reduction over time among members of a large commercial health plan with diabetes.


Charles D. Scales Jr, MD, MSHS

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Ellen M. Nielsen, MD

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


Jeffrey Clough, MD

Latest:

Prospective or Retrospective ACO Attribution Matters for Seriously Ill Patients

This study compared beneficiary characteristics and Medicare per capita expenditures among seriously ill Medicare accountable care organization (ACO) populations defined using prospective and retrospective claims-based attribution methods.


Jonah Feldman

Latest:

Patients With BRCA-Mutated mCRPC Show Worse Outcomes vs Non-BRCA HRR mCRPC

An analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) deficiency mutations showed that patients with BRCA mutations had poor outcomes compared with those without BRCA mutations and those with non-BRCA HRR mutations.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.